(1)
Novel Sustained-Release Nateglinide Microspheres: In Vitro Evaluation for Improved Antidiabetic Therapy. JOC 2024, 23 (1), 860-870. https://doi.org/10.64149/J.Carcinog.24.6s.232-242.